Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05102474 · ClinicalTrials.gov registry record
Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 24
- Enrollment target
NCT05102474: Completed study, sponsored by University of California, San Francisco.
NCT05102474 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05102474 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Getting enough sleep is important for maximizing health and well-being. When it comes to health, sleep is as vital as regular exercise and eating a balanced diet. Not getting enough sleep can lead to health problems like heart attacks, diabetes, and even cancer. Since individuals with psoriasis have these same health problems, getting better sleep may help to keep them happier and healthier. This study will look at how individuals with psoriasis sleep and if their sleep is different than indivuduals without psoriasis.
Primary Outcome
Sleep efficiency is defined as the percentage of time spent asleep while in bed.
Interventions
- OTHER Polysomnography (PSG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2024-07-03 |
What the finished NCT05102474 record still lists
NCT05102474 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Polysomnography (PSG) is the first listed.
NCT05102474 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05102474 about?
NCT05102474 is a clinical study titled "Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis". Getting enough sleep is important for maximizing health and well-being. When it comes to health, sleep is as vital as regular exercise and eating a balanced diet. Not getting enough sleep can lead to health problems like heart attacks, diabetes, and even cancer. Since individuals with psoriasis have...
What is the current status of trial NCT05102474?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2022-02-15. Estimated completion is 2024-07-03.
What interventions are being tested in trial NCT05102474?
The interventions under investigation include: Polysomnography (PSG) (OTHER).
Who is sponsoring clinical trial NCT05102474?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI